Publications and presentations

2024 |2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 a starší

 

2024

Articles in international journals

  • Christiansen SN, Horskjær Rasmussen S, Pons M, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft AG, Rotar Z, Pirkmajer KP, Nissen MJ, Baranová J, Macfarlane GJ, Jones GT, Iannone F, Caporali R, Laas K, Vorobjov S, Giuseppe DD, Olofsson T, Provan SA, Fagerli KM, Castrejon I, Otero-Varela L, van de Sande M, van der Horst-Bruinsma I, Nordström D, Kuusalo L, Bernardes M, Hetland ML, Østergaard M, Midtbøll Ørnbjerg L.
    Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
    Semin Arthritis Rheum. 2024 Jan 26;65:152388. doi: 10.1016/j.semarthrit.2024.152388. Epub ahead of print. PMID: 38301349.
  • Lauper K, Iudici M, Mongin D, Bergstra SA, Choquette D, Codreanu C, Cordtz R, De Cock D, Dreyer L, Elkayam O, Hauge EM, Huschek D, Hyrich KL, Iannone F, Inanc N, Kearsley-Fleet L, Kristianslund EK, Kvien TK, Leeb BF, Lukina G, Nordström DC, Pavelka K, Pombo-Suarez M, Rotar Z, Santos MJ, Strangfeld A, Verschueren P, Courvoisier DS, Finckh A.
    Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
    Ann Rheum Dis. 2022 Oct;81(10):1358-1366. doi: 10.1136/annrheumdis-2022-222586. Epub 2022 Jun 15. Erratum in: Ann Rheum Dis. 2024 Jan 2;83(1):e1. PMID: 35705376; PMCID: PMC9484385.

2023

Articles in international journals

  • Aymon R, Mongin D, Bergstra SA, Choquette D, Codreanu C, De Cock D, Dreyer L, Elkayam O, Huschek D, Hyrich KL, Iannone F, Inanc N, Kearsley-Fleet L, Koca SS, Kvien TK, Leeb BF, Lukina G, Nordström DC, Pavelka K, Pombo-Suarez M, Rodrigues A, Rotar Z, Strangfeld A, Verschueren P, Westermann R, Zavada J, Courvoisier DS, Finckh A, Lauper K.
    Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
    Ann Rheum Dis. 2023 Dec 8:ard-2023-224670. doi: 10.1136/ard-2023-224670. Epub ahead of print. PMID: 38071508.
  • Hellamand P, van de Sande MGH, Ørnbjerg LM, Klausch T, Eklund KK, Relas H, Santos MJ, Vieira-Sousa E, Loft AG, Glintborg B, Østergaard M, Lindström U, Wallman JK, Michelsen B, Fagerli KM, Castrejón I, Gudbjornsson B, Love TJ, Vencovský J, Nekvindová L, Rotar Ž, Tomšič M, Díaz-González F, Kenar G, Tuğsal HY, Iannone F, Ramonda R, Codreanu C, Mogosan C, Nissen MJ, Möller B, Hetland ML, van der Horst-Bruinsma IE.
    Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network.
    Arthritis Rheumatol. 2023 Nov 16. doi: 10.1002/art.42758.
  • Linde L, Ørnbjerg LM, Brahe CH, Wallman JK, Di Giuseppe D, Závada J, Castrejon I, Díaz-Gonzalez F, Rotar Z, Tomšič M, Glintborg B, Gudbjornsson B, Geirsson AJ, Michelsen B, Kristianslund EK, Santos MJ, Barcelos A, Nordström D, Eklund KK, Ciurea A, Nissen M, Akar S, Hyldstrup LH, Krogh NS, Hetland ML, Østergaard M.
    Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
    Rheumatology (Oxford). 2023 Sep 20:kead494. doi: 10.1093/rheumatology/kead494. Epub ahead of print. PMID: 37738257.
  • Linde L, Ørnbjerg LM, Rasmussen SH, Love TJ, Loft AG, Závada J, Vencovský J, Laas K, Nordstrom D, Sokka-Isler T, Gudbjornsson B, Gröndal G, Iannone F, Ramonda R, Hellamand P, Kristianslund EK, Kvien TK, Rodrigues AM, Santos MJ, Codreanu C, Rotar Z, Tomšič M, Castrejon I, Díaz-Gonzáles F, Di Giuseppe D, Ljung L, Nissen MJ, Ciurea A, Macfarlane GJ, Heddle M, Glintborg B, Østergaard M, Hetland ML.
  • Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.
    Arthritis Res Ther. 2023 Oct 19;25(1):205. doi: 10.1186/s13075-023-03184-7. PMID: 37858143; PMCID: PMC10585911.
  • Michelsen B, Østergaard M, Nissen MJ, Ciurea A, Möller B, Ørnbjerg LM, Zavada J, Glintborg B, MacDonald A, Laas K, Nordström D, Gudbjornsson B, Iannone F, Hellmand P, Kvien TK, Rodrigues AM, Codreanu C, Rotar Z, Castrejón Fernández I, Wallman JK, Vencovsky J, Loft AG, Heddle M, Vorobjov S, Hokkanen AM, Gröndal G, Sebastiani M, van de Sande M, Kristianslund EK, Santos MJ, Mogosan C, Tomsic M, Díaz-González F, Di Giuseppe D, Hetland ML.
    Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.
    Lancet Reg Health Eur. 2023 Aug 4;33:100706. doi: 10.1016/j.lanepe.2023.100706. PMID: 37601339; PMCID: PMC10432193.
  • Pombo-Suarez M, Sanchez-Piedra C, Gómez-Reino J, Lauper K, Mongin D, Iannone F, Pavelka K, Nordström DC, Inanc N, Codreanu C, Hyrich KL, Choquette D, Strangfeld A, Leeb BF, Rotar Z, Rodrigues A, Kristianslund EK, Kvien TK, Elkayam O, Lukina G, Bergstra SA, Finckh A, Courvoisier DS.
    After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
    Ann Rheum Dis. 2023 Feb;82(2):175-181. doi: 10.1136/ard-2022-222835. Epub 2022 Sep 13. PMID: 36100351.
  • Ørnbjerg LM, Rugbjerg K, Georgiadis S, Rasmussen SH, Lindström U, Pavelka K, Yilmaz N, Favalli EG, Nissen MJ, Michelsen B, Vieira-Sousa E, Jones GT, Ionescu R, Relas H, Sanchez-Piedra C, Tomšič M, Geirsson AJ, van der Horst-Bruinsma I, Askling J, Loft AG, Nekvindova L, Direskeneli H, Iannone F, Ciurea A, Fagerli KM, Santos MJ, Macfarlane GJ, Codreanu C, Eklund K, Pombo-Suarez M, Rotar Z, Gudbjornsson B, Rusman T, Østergaard M, Hetland ML.
    One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
    J Rheumatol. 2023 Aug;50(8):1009-1019. doi: 10.3899/jrheum.220459. Epub 2022 Dec 1. PMID: 36455943.
  • Linde L, Ørnbjerg LM, Georgiadis S, Rasmussen SH, Lindström U, Askling J, Michelsen B, Di Giuseppe D, Wallman JK, Gudbjornsson B, Love TJ, Nordström DC, Yli-Kerttula T, Nekvindová L, Vencovský J, Iannone F, Cauli A, Loft AG, Glintborg B, Laas K, Rotar Z, Tomšič M, Macfarlane GJ, Möller B, van de Sande M, Codreanu C, Nissen MJ, Birlik M, Erten S, Santos MJ, Vieira-Sousa E, Hetland ML, Østergaard M.
    Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor: results from 13 European registries.
    Rheumatology (Oxford). 2023 Jun 14:kead284. doi: 10.1093/rheumatology/kead284. Epub ahead of print. PMID: 37314967.

ATTRA abstracts at EULAR congresses

  • 2023 POS1549  BETTER DRUG SURVIVAL ON MONOCLONAL ANTIBODIES COMPARED TO ETANERCEPT IN FIRST LINE ANTI-TNF THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS MAY BE DUE TO DIFFERENTIAL THERAPEUTIC RESPONSE IN SKIN INVOLVEMENT: A PROPENSITY SCORE-MATCHED ANALYSIS FROM THE NATIONWIDE CZECH ATTRA REGISTRY,
  • Š. Tichý, L. Nekvindová, J. Baranová, K. Pavelka, P. Horak, J. Vencovský, J. Zavada
  • 2023 POS0656  DOES RADIOGRAPHIC STATUS IMPACT SECUKINUMAB EFFECTIVENESS IN EUROPEAN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED IN ROUTINE CARE?,
  • S. N. Christiansen, S. H. Rasmussen, M. Østergaard, B. Michelsen, K. Pavelka, C. Codreanu, A. Ciurea, B. Glintborg, M. J. Santos, İ. Sari, Z. Rotar, B. Gudbjornsson, J. Zavada, C. Mogosan, M. J. Nissen, A. G. Loft, A. Barcelos, Y. Erez, K. Pirkmajer, G. Gröndal, M. L. Hetland, L. Midtbøll Ørnbjerg
  • 2023 POS1523  EFFICACY OF SECUKINUMAB ON INDIVIDUAL DOMAINS OF PSORIATIC ARTHRITIS: EXPERIENCE FROM ROUTINE CLINICAL PRACTICE IN THE CZECH NATIONAL REGISTRY ATTRA,
  • K. Pavelka, L. Klementová, J. Baranová, J. Zavada, T. Philipp, Š. Tichý, H. Mann
  • 2023 POS1548  ENTHESITIS OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS INITIATING A TUMOUR NECROSIS FACTOR INHIBITOR IN A REAL-WORLD SETTING: DATA FROM THE EuroSpA COLLABORATION NETWORK,
  • A. J. Mathew, L. Midtbøll Ørnbjerg, M. Pedersen, S. Georgiadis, B. Glintborg, A. G. Loft, M. J. Nissen, B. Moeller, A. M. Rodrigues, F. M. Pimentel-Santos, Z. Rotar, M. Tomšič, H. Relas, R. Peltomaa, B. Gudbjornsson, T. J. Löve, S. B. Kocaer, A. Köken Avşar, M. L. Hetland, M. Østergaard
  • 2023 POS0374  HOW WELL DO EULAR/ASAS-EULAR AND NATIONAL TREATMENT RECOMMENDATIONS FOR PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS ALIGN? IS IT TIME FOR AN UPDATE OF NATIONAL TREATMENT RECOMMENDATIONS?,
  • B. Michelsen, M. J. Nissen, A. Ciurea, B. Moeller, L. Midtbøll Ørnbjerg, J. Zavada, B. Glintborg, A. Macdonald, K. Laas, D. Nordström, B. Gudbjornsson, F. Iannone, P. Hellamand, T. K. Kvien, A. M. Rodrigues, C. Codreanu, Z. Rotar, I. Castrejon, J. K. Wallman, J. Vencovský, A. G. Loft, M. Heddle, S. Vorobjov, A. M. Hokkanen, G. Gröndal, M. Sebastiani, M. G. H. Van de Sande, E. Kristianslund, M. J. Santos, C. Mogosan, M. Tomsic, F. Diaz-Gonzalez, D. DI Giuseppe, M. Østergaard, M. L. Hetland
  • 2023 POS0249  SEX DIFFERENCES IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: RESULTS FROM A MULTINATIONAL OBSERVATIONAL COHORT STUDY,
  • P. Hellamand, M. G. H. Van de Sande, M. T. Nurmohamed, R. Van Vollenhoven, R. Hollick, O. Rotariu, Z. Rotar, K. Pirkmajer, D. Nordström, A. M. Hokkanen, B. Michelsen, T. K. Kvien, B. Glintborg, A. G. Loft, K. Pavelka, J. Zavada, I. Castrejon, L. Otero-Varela, B. Gudbjornsson, O. Palsson, M. Østergaard, M. L. Hetland, J. K. Wallman, D. DI Giuseppe, A. Ciurea, M. J. Nissen, T. Demirci Yildirim, F. Onen, C. Codreanu, C. Mogosan, M. J. Santos, E. Vieira-Sousa, F. Iannone, G. Lapadula, L. Midtbøll Ørnbjerg, J. Twisk, I. Van der Horst-Bruinsma

Abstracts from ACR Congresses

  • ABSTRACT NUMBER: 1439 • ACR Convergence 2023 Better Drug Retention on anti-IL17A Compared to Anti-TNF Therapy Despite Its Inferior Effect on Composite Joint Indexes and Quality of Life in Patients with PsA–analysis from the Czech Biologics Registry ATTRA
    Jakub Zavada, Jana Baranová, Karel Pavelka, Jiri Vencovsky, Pavel Horak, Lenka Klementová and Ladislav Senolt
  • ABSTRACT NUMBER: 1849 • ACR Convergence 2023 Impact of the First Three Waves of the Covid-19 Pandemic on Everyday Restrictions and Clinical Care of Patients with Spondyloarthritis Across Europe – Results from the EuroSpA Collaboration
    Brigitte Michelsen, Bente Glintborg, Kim Lauper, Bjorn Gudbjornsson, Lykke Ørnbjerg, Gerdur Maria Gröndal, Karin Laas, Sigrid Vorobjov, Dan Nordstrom, Heikki Relas, Adrian Ciurea, Burkhard Moeller, Isabel Castrejon, Lucia Otero-Valera, Ziga Rotar, Katja Perdan Pirkmajer, Anne Gitte Loft, Jakub Zavada, Karel Pavelka, Eirik Kristianslund, Tore Kvien, Marleen van de Sande, Pasoon Hellamand, Florenzo Iannone, Roberto F. Caporali, Ana Maria Rodrigues, Maria Jose Santos, Catalin Codreanu, Corina Mogosan, Merete Hetland and Mikkel Østergaard

2022

Articles in international journals

  • Lauper K, Iudici M, Mongin D, Bergstra SA, Choquette D, Codreanu C, Cordtz R, De Cock D, Dreyer L, Elkayam O, Hauge EM, Huschek D, Hyrich KL, Iannone F, Inanc N, Kearsley-Fleet L, Kristianslund EK, Kvien TK, Leeb BF, Lukina G, Nordström DC, Pavelka K, Pombo-Suarez M, Rotar Z, Santos MJ, Strangfeld A, Verschueren P, Courvoisier DS, Finckh A.
    Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration
    Ann Rheum Dis. ; 2022 Oct;81(10):1358-1366. doi: 10.1136/annrheumdis-2022-222586. Epub 2022 Jun 15. Erratum in: Ann Rheum Dis. 2024 Jan 2;83(1):e1. PMID: 35705376; PMCID: PMC9484385.
  • Pombo-Suarez M, Sanchez-Piedra C, Gómez-Reino J, Lauper K, Mongin D, Iannone F, Pavelka K, Nordström DC, Inanc N, Codreanu C, Hyrich KL, Choquette D, Strangfeld A, Leeb BF, Rotar Z, Rodrigues A, Kristianslund EK, Kvien TK, Elkayam O, Lukina G, Bergstra SA, Finckh A, Courvoisier DS.
    After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
    Ann Rheum Dis. 2023 Feb;82(2):175-181. doi: 10.1136/ard-2022-222835. Epub 2022 Sep 13. PMID: 36100351.
  • Christiansen SN, Ørnbjerg LM, Rasmussen SH, Loft AG, Askling J, Iannone F, Zavada J, Michelsen B, Nissen M, Onen F, Santos MJ, Pombo-Suarez M, Relas H, Macfarlane GJ, Tomsic M, Codreanu C, Gudbjornsson B, Van der Horst-Bruinsma I, Di Giuseppe D, Glintborg B, Gremese E, Pavelka K, Kristianslund EK, Ciurea A, Akkoc N, Barcelos A, Sánchez-Piedra C, Peltomaa R, Jones GT, Rotar Z, Ionescu R, Grondal G, Van de Sande MGH, Laas K, Østergaard M, Hetland ML.
    European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
    Rheumatology (Oxford). 2022 Aug 30;61(9):3799-3807. doi: 10.1093/rheumatology/keab945. PMID: 34940840.
  • Michelsen B, Georgiadis S, Di Giuseppe D, Loft AG, Nissen MJ, Iannone F, Pombo-Suarez M, Mann H, Rotar Z, Eklund KK, Kvien TK, Santos MJ, Gudbjornsson B, Codreanu C, Yilmaz S, Wallman JK, Brahe CH, Möller B, Favalli EG, Sánchez-Piedra C, Nekvindova L, Tomsic M, Trokovic N, Kristianslund EK, Santos H, Löve TJ, Ionescu R, Pehlivan Y, Jones GT, van der Horst-Bruinsma I, Ørnbjerg LM, Østergaard M, Hetland ML.
    Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
    Arthritis Care Res (Hoboken). 2022 Jul;74(7):1205-1218. doi: 10.1002/acr.24560. Epub 2022 Apr 29. PMID: 33460531.
  • Nissen M, Delcoigne B, Di Giuseppe D, Jacobsson L, Hetland ML, Ciurea A, Nekvindova L, Iannone F, Akkoc N, Sokka-Isler T, Fagerli KM, Santos MJ, Codreanu C, Pombo-Suarez M, Rotar Z, Gudbjornsson B, van der Horst-Bruinsma I, Loft AG, Möller B, Mann H, Conti F, Yildirim Cetin G, Relas H, Michelsen B, Avila Ribeiro P, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Askling J, Glintborg B, Lindström U.
    The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
    Rheumatology (Oxford). 2022 Nov 28;61(12):4741-4751. doi: 10.1093/rheumatology/keac174. PMID: 35323903.
  • Ørnbjerg LM, Linde L, Georgiadis S, Rasmussen SH, Lindström U, Askling J, Michelsen B, Giuseppe DD, Wallman JK, Pavelka K, Závada J, Nissen MJ, Jones GT, Relas H, Pirilä L, Tomšič M, Rotar Z, Geirsson AJ, Gudbjornsson B, Kristianslund EK, van Sder Horst-Bruinsma I, Loft AG, Laas K, Iannone F, Corrado A, Ciurea A, Santos MJ, Santos H, Codreanu C, Akkoc N, Gunduz OS, Glintborg B, Østergaard M, Hetland ML.
    Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
    Semin Arthritis Rheum. 2022 Oct;56:152081. doi: 10.1016/j.semarthrit.2022.152081. Epub 2022 Aug 10. Erratum in: Semin Arthritis Rheum. 2023 Feb;58:152141. PMID: 35985172.
  • Ørnbjerg LM, Rugbjerg K, Georgiadis S, Rasmussen SH, Lindström U, Pavelka K, Yilmaz N, Favalli EG, Nissen MJ, Michelsen B, Vieira-Sousa E, Jones GT, Ionescu R, Relas H, Sanchez-Piedra C, Tomšič M, Geirsson AJ, van der Horst-Bruinsma I, Askling J, Loft AG, Nekvindova L, Direskeneli H, Iannone F, Ciurea A, Fagerli KM, Santos MJ, Macfarlane GJ, Codreanu C, Eklund K, Pombo-Suarez M, Rotar Z, Gudbjornsson B, Rusman T, Østergaard M, Hetland ML.
    One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
    J Rheumatol. 2023 Aug;50(8):1009-1019. doi: 10.3899/jrheum.220459. Epub 2022 Dec 1. PMID: 36455943.

ATTRA abstracts at EULAR congresses

  • 2022 POS0567  SELF-PERCEIVED GENERAL HEALTH AT START OF ANTI-TNF THERAPY PREDICTS THERAPEUTIC RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS FROM THE CZECH BIOLOGICS REGISTRY ATTRA,
    J. Zavada, L. Nekvindova on behalf of Collaborators of the ATTRA registry

2021

Articles in international journals

ATTRA abstracts at EULAR congresses

  • 2021 OP0105    FEASIBILITY AND USEFULNESS OF MAPPING BIOLOGIC REGISTRIES TO A COMMON DATA MODEL: ILLUSTRATION USING COMORBIDITIES,
    L. Kearsley-Fleet, K. Hyrich, M. Schaefer, D. Huschek, A. Strangfeld, J. Zavada, M. Lagová, D. Courvoisier, C. Tellenbach, K. Lauper, C. Sánchez-Piedra, N. Montero, J. T. Sánchez-Costa, D. Prieto-Alhambra, E. Burn

  • 2021 POS0093  HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY),
    K. Lauper, D. Mongin, S. A. Bergstra, D. Choquette, C. Codreanu, D. De Cock, L. Dreyer, O. Elkayam, K. Hyrich, F. Iannone, N. Inanc, E. Kristianslund, T. K. Kvien, B. Leeb, G. Lukina, D. Nordström, K. Pavelka, M. Pombo-Suarez, Z. Rotar, M. J. Santos, A. Strangfeld, D. Courvoisier, A. Finckh on behalf of Epidemiology and registry working group

  • 2021 POS0596  THE THERAPEUTIC TARGET IS REACHED MORE OFTEN IN RA PATIENTS STARTING TNF INHIBITORS WITH MODERATE ACTIVITY THAN WITH HIGH DISEASE ACTIVITY – AN ANALYSIS FROM THE ATTRA REGISTRY,
    K. Pavelka, L. Nekvindova, J. Zavada

Abstracts from ACR Congresses

  • ABSTRACT NUMBER: 0237 • ACR Convergence 2021 Self-perceived General Health at Start of Anti-TNF Therapy Predicts Therapeutic Response in Patients with Rheumatoid Arthritis: Analysis from the Czech Biologics Registry ATTRA
    Jakub Zavada and Lucie Nekvindova

2020

Articles in international and Czech journals

  • Zavada, Jakub; Nekvindova, Lucie.
    Treat-to-target Strategy in Patients with Rheumatoid Arthritis in Daily Clinical Practice -still Underused, but Superior to Routine Care: A Propensity Score Matched Analysis from the ATTRA Registry
    ARTHRITIS & RHEUMATOLOGY; OCT 2020; 72,
  • Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K.; Kvien, Tore K.; Nordström, Dan C.; Pavelka, Karel; Pombo-Suarez, Manuel; Rotar, Ziga; Santos, Maria J.; Codreanu, Catalin; Lukina, Galina; Gale, Sara L.; John, Markus; Luder, Yves; Courvoisier, Delphine S.; Gabay, Cem.
    Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis
    Seminars in Arthritis and Rheumatism Volume: 50 Issue 1 (2020), 50(1):17-24.
  • Tužil J, Mlčoch T, Jirčíková J, Závada J, Nekvindová L, Svoboda M, Uher M, Křístková Z, Vencovský J, Pavelka K, Doležal T.
    Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.
    Expert Opin Biol Ther. 2020 Feb;20(2):183-192. doi: 10.1080/14712598.2020.1694900.
  • Michelsen B, Lindström U, Codreanu C, Ciurea A, Zavada J, Loft AG, Pombo-Suarez M, Onen F, Kvien TK, Rotar Z, Santos MJ, Iannone F, Hokkanen AM, Gudbjornsson B, Askling J, Ionescu R, Nissen MJ, Pavelka K, Sanchez-Piedra C, Akar S, Sexton J, Tomsic M, Santos H, Sebastiani M, Österlund J, Geirsson AJ, Macfarlane G, van der Horst-Bruinsma I, Georgiadis S, Brahe CH, Ørnbjerg LM, Hetland ML, Østergaard M.
    Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.
    RMD Open. 2020 Sep;6(3):e001280. doi: 10.1136/rmdopen-2020-001280.
  • Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML.
    Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
    Rheumatology (Oxford). 2020 Jul 1;59(7):1640-1650. doi: 10.1093/rheumatology/kez427.
  • PAVELKA, Karel — KŘÍSTKOVÁ, Zlatuše — DUŠEK, Ladislav.
    Národní registr biologické a cílené léčby revmatických onemocnění ATTRA – 20leté zkušenosti.
    Česká revmatologie, 2020, roč. 28, č. 3, s. 120-131
  • ŠENOLT, Ladislav — SVOBODA, Michal.
    Zkušenost s inhibitory Janusových kináz v reálné praxi z registru ATTRA.
    Farmakoterapeutická revue, 2020, roč. 5, č. 3, s. 221-229. ISSN: 2533-6878.
  • Michelsen B, Ørnbjerg LM, Kvien TK, Pavelka K, Nissen MJ, Nordström D, Santos MJ, Koca SS, Askling J, Rotar Z, Gudbjornsson B, Codreanu C, Loft AG, Kristianslund EK, Mann HF, Ciurea A, Eklund KK, Vieira-Sousa E, Yazici A, Jacobsson L, Tomšič M, Löve TJ, Ionescu R, van der Horst-Bruinsma IE, Iannone F, Pombo-Suarez M, Jones GT, Hyldstrup LH, Krogh NS, Hetland ML, Østergaard M.
    Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
    Rheumatology (Oxford). 2020 Sep 1;59(9):2455-2461. doi: 10.1093/rheumatology/kez656. PMID: 31960053.
  • Michelsen B, Lindström U, Codreanu C, Ciurea A, Zavada J, Loft AG, Pombo-Suarez M, Onen F, Kvien TK, Rotar Z, Santos MJ, Iannone F, Hokkanen AM, Gudbjornsson B, Askling J, Ionescu R, Nissen MJ, Pavelka K, Sanchez-Piedra C, Akar S, Sexton J, Tomsic M, Santos H, Sebastiani M, Österlund J, Geirsson AJ, Macfarlane G, van der Horst-Bruinsma I, Georgiadis S, Brahe CH, Ørnbjerg LM, Hetland ML, Østergaard M.
    Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.
    RMD Open. 2020 Sep;6(3):e001280. doi: 10.1136/rmdopen-2020-001280. PMID: 32950963; PMCID: PMC7539854.
  • Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML.
    Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
    Rheumatology (Oxford). 2020 Jul 1;59(7):1640-1650. doi: 10.1093/rheumatology/kez427. PMID: 31665497.

ATTRA abstracts at EULAR congresses

  • 2020 OP0109    CO-MEDICATION WITH A CONVENTIONAL SYNTHETIC DMARD IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS IS ASSOCIATED WITH IMPROVED RETENTION OF TNF INHIBITORS: RESULTS FROM THE EUROSPA COLLABORATION,
    M. Nissen, B. Delcoigne, D. DI Giuseppe, L. T. H. Jacobsson, K. Fagerli, A. G. Loft, A. Ciurea, D. Nordström, Z. Rotar, F. Iannone, M. J. Santos, M. Pombo-Suarez, B. Gudbjornsson, H. Mann, N. Akkoc, C. Codreanu, I. Van der Horst-Bruinsma, B. Michelsen, G. Macfarlane, M. L. Hetland, M. Tomsic, B. Moeller, P. Ávila-Ribeiro, C. Sánchez-Piedra, H. Relas, A. J. Geirsson, L. Nekvindova, G. Yildirim Cetin, R. Ionescu, N. Steen Krogh, J. Askling, B. Glintborg, U. Lindström
  • 2020 FRI0283    CO-MEDICATION WITH CSDMARD HAS LITTLE EFFECT ON THE RETENTION OF TNF INHIBITORS IN PSORIATIC ARTHRITIS, RESULTS FROM THE EUROSPA COLLABORATION,
    U. Lindström, D. DI Giuseppe, B. Delcoigne, B. Glintborg, B. Moeller, M. Pombo-Suarez, C. Sánchez-Piedra, K. Eklund, H. Relas, B. Gudbjornsson, T. Love, G. T. Jones, A. Ciurea, C. Codreanu, R. Ionescu, L. Nekvindova, J. Zavada, N. Atas, S. Yolbaş, K. Fagerli, B. Michelsen, Z. Rotar, M. Tomsic, F. Iannone, M. J. Santos, P. Ávila-Ribeiro, L. Midtbøll Ørnbjerg, M. Ǿstergaard, L. T. H. Jacobsson, J. Askling, M. Nissen
  • 2020 OP0231    COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY),
    K. Lauper, D. Mongin, S. A. Bergstra, D. Choquette, C. Codreanu, D. De Cock, L. Dreyer, O. Elkayam, K. Hyrich, F. Iannone, N. Inanc, E. Kristianslund, T. K. Kvien, B. Leeb, G. Lukina, D. Nordström, K. Pavelka, M. Pombo-Suarez, Z. Rotar, M. J. Santos, A. Strangfeld, D. Courvoisier, A. Finckh
  • 2020 AB1233    GENDER DIFFERENCE IN DISEASE SEVERITY AND TREATMENT OUTCOMES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA), AXIAL SPONDYLOARTHRITIS (AXSPA) AND PSORIATIC ARTHRITIS (PSA) STARTING TREATMENT WITH TARGETED THERAPY IN THE CZECH REPUBLIC,
    J. Zavada, L. Nekvindova, K. Pavelka, P. Horak, J. Vencovský on behalf of collaborators of the ATTRA registry
  • 2020 OP0285    TOWARDS IMPLEMENTING THE OMOP CDM ACROSS FIVE EUROPEAN BIOLOGIC REGISTRIES,
    E. Burn, L. Kearsley-Fleet, K. Hyrich, M. Schaefer, D. Huschek, A. Strangfeld, J. Zavada, M. Lagová, D. Courvoisier, C. Tellenbach, K. Lauper, C. Sánchez-Piedra, N. Montero, J. T. Sanchez-Costa, D. Prieto-Alhambra

Abstracts from ACR Congresses

  • ABSTRACT NUMBER: 0813 • ACR Convergence 2020 Treatment Outcomes in Patients with Seropositive versus Seronegative Rheumatoid Arthritis in Czech Registry ATTRA Treated with JAK Inhibitors
    Karel Pavelka and Zlatuše Křístková
  • ABSTRACT NUMBER: 0816 • ACR Convergence 2020 Treat-to-target Strategy in Patients with Rheumatoid Arthritis in Daily Clinical Practice -still Underused, but Superior to Routine Care: A Propensity Score Matched Analysis from the ATTRA Registry
    Jakub Závada and Lucie Nekvindova

2019

Articles in international journals

Presentations at international conferences

Annual European Congress of Rheumatology (EULAR 2019)
12.–15. 6. 2019 (Madrid, Španělsko)

Presentations at Czech conferences

Třeboňské revmatologické dny 2019
9.–11. 1. 2019, Třeboň

  • Vencovský J. Xeljanz v léčbě revmatoidní artritidy – zkušenosti z reálné klinické praxe v ČR a ve světě
  • Mann H. Terapie psoriatické artritidy sekukinumabem, výsledky z klinických studií i z běžné klinické praxe. Data získaná z registrů vč. ATTRA.
  • Mann H. Průřez monoterapií: známé i neznámé
  • Šenolt L. Obtížně léčitelný pacient s RA – teorie a realita ve světle podmínek úhrady, současná situace podle registru ATTRA (setkání center BL)

ATTRA abstracts at EULAR congresses

  • 2019 FRI0453    DOES DISCORDANCE BETWEEN BASELINE PATIENT’S AND EVALUATOR’S GLOBAL ASSESSMENT OF DISEASE ACTIVITY IMPACT RETENTION AND REMISSION RATES OF TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS? DATA FROM THE EUROSPA RESEARCH COLLABORATION,
  • Brigitte Michelsen, Lykke Ørnbjerg, Heřman Mann, Joseph Sexton, Michael Nissen, Maria Jose Santos, Dan Nordström, Lennart T.H. Jacobsson, Ziga Rotar, Björn Gudbjornsson, Süleyman Serdar Koca, Catalin Codreanu, Manuel Pombo-Suarez, Irene van der Horst-Bruinsma, Anne Gitte Loft, Karel Pavelka, Eirik Kristianslund, Burkhard Moeller, Elsa Vieira-Sousa, Anna-Mari Hokkanen, Ulf Lindström, Matija Tomsic, Thorvardur Jon Love, Berna Goker, Ruxandra Ionescu, Carlos Sánchez-Piedra, Marleen van de Sande, Gary Macfarlane, Florenzo Iannone, Lise Hyldstrup, Niels Steen Krogh, Mikkel Ǿstergaard, Merete L. Hetland
  • 2019 FRI0378    DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS DEPEND ON THE REASON FROM WITHDRAWAL FROM THE PREVIOUS TREATMENT? – RESULTS FROM THE EUROSPA RESEARCH COLLABORATION,
  • Lykke Ørnbjerg, Cecilie Heegaard Brahe, Anne Gitte Loft, Johan Askling, Adrian Ciurea, Heřman Mann, Servet Akar, Eirik Kristianslund, Dan Nordström, Maria Jose Santos, Catalin Codreanu, Manuel Pombo-Suarez, Ziga Rotar, Björn Gudbjornsson, Daniela DI Giuseppe, Michael Nissen, Karel Pavelka, Soner Senel, Joe Sexton, Kari Eklund, Anabela Barcelos, Ruxandra Ionescu, Carlos Sánchez-Piedra, Matija Tomsic, Arni Jon Geirsson, Irene van der Horst-Bruinsma, Gary Macfarlane, Florenzo Iannone, Brigitte Michelsen, Lise Hyldstrup, Niels Steen Krogh, Merete L. Hetland, Mikkel Ǿstergaard
  • 2019 SAT0614   DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? – RESULTS FROM THE EUROSPA RESEARCH COLLABORATION, Cecilie Heegaard Brahe, Lykke Ørnbjerg, Lennart T.H. Jacobsson, Michael Nissen, Eirik Kristianslund, Heřman Mann, Maria Jose Santos, Manuel Pombo-Suarez, Dan Nordström, Ziga Rotar, Björn Gudbjornsson, Ediz Dalkiliç, Catalin Codreanu, Anne Gitte Loft, Ulf Lindström, Burkhard Moeller, Joe Sexton, Karel Pavelka, Anabela Barcelos, Carlos Sánchez-Piedra, Kari Eklund, Matija Tomsic, Thorvardur Jon Love, İsmail Sari, Ruxandra Ionescu, Marleen van de Sande, Irene van der Horst-Bruinsma, Gareth T. Jones, Florenzo Iannone, Brigitte Michelsen, Lise Hyldstrup, Niels Steen Krogh, Mikkel Ǿstergaard, Merete L. Hetland
  • 2019 AB0752    DRUG RETENTION AND REMISSION RATES IN 14,261 BIOLOGIC-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS STARTING TNF INHIBITOR TREATMENT IN ROUTINE CARE – RESULTS FROM 12 REGISTRIES IN THE EUROSPA RESEARCH COLLABORATION,
  • Cecilie Heegaard Brahe, Lykke Ørnbjerg, Lennart T.H. Jacobsson, Michael Nissen, Eirik Kristianslund, Heřman Mann, Maria Jose Santos, Manuel Pombo-Suarez, Dan Nordström, Ziga Rotar, Björn Gudbjornsson, Fatos Onen, Catalin Codreanu, Ulf Lindström, Burkhard Moeller, Joe Sexton, Karel Pavelka, Anabela Barcelos, Carlos Sánchez-Piedra, Kari Eklund, Matija Tomsic, Thorvardur Jon Love, Gerçek Can, Ruxandra Ionescu, Anne Gitte Loft, Marleen van de Sande, Irene van der Horst-Bruinsma, Gary Macfarlane, Florenzo Iannone, Lise Hyldstrup, Niels Steen Krogh, Mikkel Ǿstergaard, Merete L. Hetland
  • 2019 FRI0403    HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION,
  • Brigitte Michelsen, Lykke Ørnbjerg, Anne Gitte Loft, Joseph Sexton, Adrian Ciurea, Heřman Mann, Kari Eklund, Ayten Yazici, Maria Jose Santos, Johan Askling, Ziga Rotar, Björn Gudbjornsson, Manuel Pombo-Suarez, Catalin Codreanu, Irene van der Horst-Bruinsma, Eirik Kristianslund, Michael Nissen, Karel Pavelka, Nina Trokovic, Nevsun Inanc, Elsa Vieira-Sousa, Daniela DI Giuseppe, Matija Tomsic, Arni Jon Geirsson, Ruxandra Ionescu, Marleen van de Sande, Florenzo Iannone, Carlos Sánchez-Piedra, Gareth T. Jones, Lise Hyldstrup, Niels Steen Krogh, Merete L. Hetland, Mikkel Ǿstergaard
  • 2019 FRI0404    POOLED 6-MONTH TREATMENT OUTCOMES AND DRUG RETENTION RATES IN 1556 PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH SECUKINUMAB IN ROUTINE CLINICAL PRACTICE IN 12 EUROPEAN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION,
  • Brigitte Michelsen, Cecilie Heegaard Brahe, Johan Askling, Catalin Codreanu, Adrian Ciurea, Anne Gitte Loft, Heřman Mann, Manuel Pombo-Suarez, Fatos Onen, Joe Sexton, Ziga Rotar, Maria Jose Santos, Kari Eklund, Björn Gudbjornsson, Florenzo Iannone, Daniela DI Giuseppe, Ruxandra Ionescu, Michael Nissen, Karel Pavelka, Carlos Sánchez-Piedra, Servet Akar, Eirik Kristianslund, Matija Tomsic, Helena Santos, Nina Trokovic, Arni Jon Geirsson, Ennio Giulio Favalli, Irene van der Horst-Bruinsma, Gary Macfarlane, Lise Hyldstrup, Niels Steen Krogh, Mikkel Ǿstergaard, Merete L. Hetland
  • 2019 SAT0391   REMISSION AND DRUG RETENTION RATES OF SECUKINUMAB IN 1549 PATIENTS WITH PSORIATIC ARTHRITIS TREATED IN ROUTINE CARE – POOLED DATA FROM THE OBSERVATIONAL EUROSPA RESEARCH COLLABORATION NETWORK,
  • Brigitte Michelsen, Cecilie Heegaard Brahe, Lennart T.H. Jacobsson, Michael Nissen, Manuel Pombo-Suarez, Heřman Mann, Ziga Rotar, Joe Sexton, Maria Jose Santos, Dan Nordström, Catalin Codreanu, Björn Gudbjornsson, Sema Yilmaz, Florenzo Iannone, Ulf Lindström, Anne Gitte Loft, Burkhard Moeller, Carlos Sánchez-Piedra, Karel Pavelka, Matija Tomsic, Eirik Kristianslund, Helena Santos, Anna-Mari Hokkanen, Ruxandra Ionescu, Thorvardur Jon Love, Yavuz Pehlivan, Marco Sebastiani, Gareth T. Jones, Irene van der Horst-Bruinsma, Lise Hyldstrup, Niels Steen Krogh, Merete L. Hetland, Mikkel Ǿstergaard
  • 2019 FRI0107    THE EFFECT OF CO-MEDICATION WITH METHOTREXATE OR OTHER CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ON FIRST TUMOR NECROSIS INHIBITOR DRUG SURVIVAL IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE CZECH ATTRA REGISTRY,
  • Heřman Mann, Lucie Nekvindova, Jakub Zavada, Ladislav Šenolt, Pavel Horak, Zlatuse Kristkova, Jiří Vencovský, Karel Pavelka
  • 2019 SAT0625   TREATMENT RESPONSE AND DRUG RETENTION RATES IN 23,956 BIOLOGIC-NAïVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING TNFI TREATMENT – ROUTINE CARE DATA FROM 12 REGISTRIES IN THE EUROSPA COLLABORATION,
  • Lykke Ørnbjerg, Cecilie Heegaard Brahe, Anne Gitte Loft, Johan Askling, Adrian Ciurea, Heřman Mann, Fatos Onen, Eirik Kristianslund, Dan Nordström, Maria Jose Santos, Catalin Codreanu, Manuel Pombo-Suarez, Ziga Rotar, Björn Gudbjornsson, Daniela DI Giuseppe, Michael Nissen, Karel Pavelka, Merih Birlik, Joe Sexton, Kari Eklund, Anabela Barcelos, Ruxandra Ionescu, Carlos Sánchez-Piedra, Matija Tomsic, Arni Jon Geirsson, Irene van der Horst-Bruinsma, Gareth T. Jones, Florenzo Iannone, Lise Hyldstrup, Niels Steen Krogh, Merete L. Hetland, Mikkel Ǿstergaard

2018

Articles in international journals

Articles in Czech journals

Presentations at international conferences

Annual European Congress of Rheumatology (EULAR)
13.–16. 6. 2018 (Amsterodam, Nizozemsko)

ACR/ARHP Annual Meeting
19.–24. 10. 2018 (Chicago, Illinois, USA)

  • Mann, HF ; Zavada, J ; Nekvindova, L ; Kristkova, Z  ; Horak, P; Vencovsky, J ; Pavelka, K: Real-World Use of Secukinumab in Axial Spondyloarthritis: First Year Data from the Czech National Registry. ARTHRITIS & RHEUMATOLOGY 2018, 70 (9) Meeting Abstract: 2591
  • Mann, HF ; Zavada, J  ; Nekvindova, L ; Kristkova, Z  ; Horak, P  ; Vencovsky, J ; Pavelka, K: Real-World Use of Secukinumab in Psoriatic Arthritis: First Year Data from the Czech National Registry. ARTHRITIS & RHEUMATOLOGY 2018, 70 (9) Meeting Abstract: 2592

Odborné příspěvky na českých konferencích

Zimní revmatologické dny 2018
10.–12. 1. 2018, Plzeň, ČR

  • Vencovský J. Benepali – údaje z reálné klinické praxe v zemích EU a stav v ČR
  • Pavelka K. Dlouhodobé výsledky s adalimumabem v českém registru ATTRA
  • Šedová L. Zlepšování kvality života cílenou antirevmatickou léčbou
  • Mann H. Hodnocení klinické účinnosti terapie abataceptem na podkladě stratifikace podle ACPA protilátek

62. výroční sjezd českých a slovenských revmatologů
20.–22. 9. 2018, Praha

  • Pavelka Karel, Svoboda M, Křístková Z
    Dlouhodobé výsledky léčby spondyloartritid golimumabem v klinických studiích a reálné praxi
    Česká revmatologie. 2018, roč. 26, č. 3, s. 189. ISSN: 1210-7905; 1805-4463

ATTRA abstracts at EULAR congresses

  • 2018 THU0317  Creating a european database of psoriatic arthritis patients treated in routine care – first, preliminary results from the eurospa research network collaboration,
    L.M. Ørnbjerg, M. Østergaard, F. Onen, M. Birlik, Z. Rotar, M. Tomsic, B. Gudbjornsson, T.J. Love, M.J. Nissen, A. Ciurea, D. Nordström, N. Trokovic, M.J. Santos, A. Barcelos, E.K. Kristianslund, T. Kvien, C. Codreanu, E.-M. Hauge, J.
  • 2018 SAT0291   Creation of a european database of patients with axial spondyloarthritis treated in clinical practice– initial, preliminary findings from the eurospa research network collaboration,
    L.M. Ørnbjerg, M. Østergaard, F. Onen, G. Can, Z. Rotar, M. Tomsic, B. Gudbjornsson, A.J. Geirsson, M.J. Santos, A. Barcelos, D. Nordström, K. Aaltonen, M.J. Nissen, A. Ciurea, E.K. Kristianslund, T. Kvien, C. Codreanu, E.-M. Hauge, L.
  • 2018 FRI0122    Drug survival of adalimumab in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis over 10 years in real-world setting of czech registry attra,
    K. Pavelka, J. Zavada, Z. Kristkova, L. Szczukova
  • 2018 SAT0285   Efficacy of early versus delayed initiation of anti-tnf-alpha treatment in axial spondyloarthritis. data from the czech registry attra,
    H. Mann, K. Bubov, J. Zavada, . Forejtov, Z. Kstkov, L. Szczukov, P. Hork, J. Vencovsky, K. Pavelka
  • 2018 THU0651  The influence of age, gender, employment status, or education on the choice of bio-similar vs. bio-original variant of the same bdmard in patients with ra or as starting biological therapy – real life data from the czech biologics registry attra,
    J. Zavada, L. Nekvindova, K. Pavelka, J. Vencovsky

2017

Articles in international journals

Presentations at international conferences

ACR/ARHP Annual Meeting
3.–8. 11. 2017 (San Diego, California, USA)

Annual European Congress of Rheumatology (EULAR)
14.–17. 6. 2017 (Madrid, Španělsko)

Presentations at Czech conferences

Třeboňské revmatologické dny 2017
4.–6. 1. 2017, Třeboň, ČR

  • Jarošová K. Léčba infliximabem u dospělých pacientů s juvenilní idiopatickou artritidou
  • Šléglová O. Máme se obávat jaterního selhání při anti TNF léčbě?
  • Horváth R. Ovlivnění kvality života pacientů s SpA léčených adalimumabem – výsledky dlouhodobého sledování v registru ATTRA

XII. Setkání českých a slovenských dětských revmatologů, revmatologických sester a fyzioterapeutů
11.–13. 5. 2017, Mikulov, ČR

  • Němcová D a kol. Biologická léčba JIA – přehled registru ATTRA

XII. Slapské symposium
8.–10. 6. 2017, Měřín, ČR

  • Pavelka K. Predikce odpovědi na anti-TNF léčbu: studie GO-MORE a reálná data z registru ATTRA
  • Závada J. Vliv anti-TNF terapie na produktivitu práce a pracovní neschopnost u pacientů s RA, SpA a PsA
  • Mann H. Může včasné nasazení biologické léčby ovlivnit léčebné výsledky pacientů s AS? (analýza z registru ATTRA)
  • Forejtová Š. Výsledky studie – switching z originálního na biosimilární infliximab

ATTRA abstracts at EULAR congresses

  • 2017 FRI0450    COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES ,
    M.L. Hetland, M. Østergaard, J. Askling, C. Gabay, D. Nordstrom, O. FitzGerald, M. Hernández Miguel, M. Santos, Z. Rotar, H. Mann, F. Iannone, M.J. Nissen, E. Hauge, J. Gomez-Reino, F. Díaz-González, M. Tomsic, K. Pavelka,
  • 2017 AB0387    COMPARISON OF ETANERCEPT IN MONOTHERAPY AND COMBINATION WITH SYNTHETIC DMARDS: DATA FROM ATTRA REGISTRY ,
    P. Horák, M. Skácelová, L. Szczuková, A. Smržová, J. Vencovsky, J. Závada, K. Pavelka
  • 2017 THU0621  COMPARISON OF THE EFFECT OF ANTI-TNF THERAPY ON WORK DISABILITY BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS OVER ONE YEAR– REAL LIFE DATA FROM THE CZECH BIOLOGICS REGISTRY ATTRA ,
    J. Zavada, L. Szczukova, J. Vencovskyy, P. Horák, K. Pavelka
  • 2017 THU0650  THE EFFECT OF ANTI-TNF THERAPY ON WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS OVER ONE YEAR – REAL LIFE DATA FROM THE CZECH BIOLOGICS REGISTRY ATTRA ,
    J. Zavada, L. Szczukova, K. Pavelka, P. Horák, J. Vencovsky

Abstracts from ACR Congresses

  • ABSTRACT NUMBER: 992 • 2017 ACR/ARHP Annual Meeting The Effect of Anti-TNF Therapy on Work Productivity and Activity Impairment  in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis over One Year – Real Life Data from the Czech Biologics Registry Attra. 
    Jakub Zavada, Lenka Szczukova, Karel Pavelka and Jiri Vencovsky
  • ABSTRACT NUMBER: 1549 • 2017 ACR/ARHP Annual Meeting A Non-Medical Switch from Originator Infliximab to Biosimilar CT-P13 in 36 Patients with Ankylosing Spondylitis:  6 – Months Clinical Outcomes from the Czech Biologic Registry Attra
    Šárka Forejtová, Jakub Zavada, Lenka Szczukova, Katerina Jarosova, Tom Philipp and Karel Pavelka

2016

Articles in international journals

Articles in Czech journals

  • Pavelka K, Šedová L, Hejduk K, Dušek L. 15 let zkušeností s biologickou léčbou zánětlivých revmatických onemocnění v národním registru ATTRA. Časopis lékařů českých 2016; 155(6): 285–292.
  • Pavelka K, Jarošová K, Suchý D, Uher M, Hejduk K. První zkušenosti s biosimilárním infliximabem CT-P13 u nemocných se zánětlivými revmatickými onemocněními v ČR v národním registru ATTRA. Česká revmatologie 2016; (24)1: 15–30.
  • Horváth R, Hurňáková J, Janková R, Philipp T, Szczuková L, Hejduk K, Pavelka K. Účinnost první a následné linie léčby adalimumabem u revmatoidní artritidy: analýza dat Českého národního registru ATTRA. Česká revmatologie 2016; 24(3): 78–91.

Odborné příspěvky na mezinárodních konferencích

Annual European Congress of Rheumatology (EULAR)
8.–11. 6. 2016 (Londýn, Anglie)

ACR/ARHP Annual Meeting
11.–16. 11. 2016 (Washington, USA)

11th Central European Congress of Rheumatology
8.–10. 12. 2016 (Praha, ČR)

  • Forejtová Š, Závada J, Szczuková L, Hejduk K, Vencovský J, Pavelka K. Comparison of the effect of anti-TNF therapy on measures of physical function and health related quality of life in patients with rheumatoid arthritis and ankylosing spondylitis – results from the Czech biologic registry ATTRA. Česká revmatologie 2016; 24(Suppl.): 49 (CECR).

ATTRA abstracts at EULAR congresses

  • 2016 AB0204    GLUCOCORTICOID-SPARING EFFECTS OF ABATACEPT IN RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH BOTH ABATACEPT EFFECTIVENESS AND SEROPOSITIVITY ,
    J.-E. Gottenberg, D. Courvoisier, M. Hetland, C. Turesson, H. Canhão, M.V. Hernandez, F. Iannone, E. Lie, K. Pavelka, D. Choquette, X. Mariette, A. Finckh
  • 2016 FRI0070    TRAJECTORIES OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS AFTER ABATACEPT INITIATION AND THEIR ASSOCIATION WITH CLINICAL CHARACTERISTICS ,
    D.S. Courvoisier, J.-E. Gottenberg, M.V. Hernandez, F. Iannone, E. Lie, H. Canhao, K. Pavelka, M. Hetland, C. Turesson, X. Mariette, D. Choquette, A. Finckh

2015

Articles in international journals

Presentations at international conferences

Annual European Congress of Rheumatology (EULAR)
10.–13. 6. 2015 (Řím, Itálie)

Controversies in Rheumatology and Autoimmunity (CORA) 2015
12.–14. 3. 2015 (Sorrento, Itálie)

  • Mann H, Forejtová Š, Jarošová K, Šenolt L, Závada J, Uher M, Hejduk K, Pavelka K. Efficacy of first line biological monotherapy in RA: data from the Czech registry ATTRA.

Presentations at Czech conferences

Třeboňské revmatologické dny 2015
7.–9. 1. 2015, Třeboň

  • Pavelka K. První zkušenosti s preparátem Remsima v registru ATTRA

ATTRA abstracts at EULAR congresses

  • 2015 AB0440    THE IMPACT OF PATIENT CHARACTERISTICS AND PAST TREATMENT HISTORY ON THE EVOLUTION OF FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH ABATACEPT. A PAN-EUROPEAN ANALYSIS OF RA REGISTRIES ,
    A. Finckh, F. Iannone, D. Neto, M. Hernández, E. Lie, H. Canhão, K. Pavelka, C. Turesson, X. Mariette, J.-E. Gottenberg, M.L. Hetland

2014 a starší

Articles in international journals

Articles in Czech journals

  • Pavelka K, Hejduk K, Mann H. Jaké jsou prediktivní faktory odpovědi na léčbu tocilizumabem v běžné klinické praxi? Zkušenosti z Českého národního registru ATTRA. Česká revmatologie 2013; 21(3): 132-139.
  • Závada J, Uher M, Hejduk K, Vencovský J, Pavelka K. Zdravím podmíněná kvalita života u pacientů s revmatoidní artritidou v průběhu prvního roku anti-TNF léčby (hodnocení). Česká revmatologie 2013; 21(3): 123-130.
  • Horák P, Skácelová M, Hejduk K, Pavelka K. Abatacept a jeho použití v České republice v léčbě RA - údaje z registru ATTRA. Česká revmatologie 2012; 20(4): 163-169.
  • Pavelka K, Chroust K, Burešová L. Rituximab v běžné klinické praxi v léčbě aktivní revmatoidní artritidy. Česká revmatologie 2011; 19(3): 112-117.
  • Šléglová O, Burešová L, Vencovský J, Pavelka K. Výskyt infekcí při léčbě antagonisty TNF alfa v registru ATTRA. Česká revmatologie 2011,19(2): 86-91.
  • Pavelka K, Gatterová J, Vencovský J, Šedová L, Chroust K. Rentgenová progrese revmatoidní artritidy v běžné klinické praxi - Výsledky z českého registru ATTRA. Rheumatologia 2009; 23(1): 7-11.

Presentations at international conferences

2014 ACR/ARHP Annual Meeting
14.–19. 11. 2014 (Boston, USA)

Annual European Congress of Rheumatology (EULAR)
11.–14. 6. 2014 (Paříž, Francie)

Annual European Congress of Rheumatology (EULAR)
12.–15. 6. 2013 (Madrid, Španělsko)

Annual European Congress of Rheumatology (EULAR)
6.–9. 6. 2012 (Berlín, Německo)

7th Central European Congress of Rheumatology
8.–10. 5. 2008 (Praha, ČR)

  • Pavelka K. Efficacy of adalimumab in RA in clinical studies and registries results from National registry ATTRA.
  • Chroust K. Project ATTRA – electronic vision.
  • Pavelka K. Inhibition of radiographic progression with infliximab in clinical studies and in real practice (registries).

Annual European Congress of Rheumatology (EULAR)
13.–16. 6. 2007 (Barcelona, Španělsko)

  • Pavelka K, Tegzova D, Pavelkova A, et al: No effect of dose escalation on infliximab in patiens with rheumatoid arthritis with residual activity – Data from national registry. Annals of the Rheumatic Diseases 2007; 66(Suppl. 2): 56.

Annual European Congress of Rheumatology (EULAR)
13.–16. 6. 2006 (Amsterdam, Nizozemsko)

  • Tegzova D, Vencovsky J, Svobodnik A, et al. Clinical register of TNFA blocking therapy of Czech rheumatological society project ATTRA: Clinical efficacy and safety. Results of 4-years study Annals of the Rheumatic Diseases 2006; 65(Suppl. 2): 505–506.

Annual European Congress of Rheumatology (EULAR)
9.–12. 6. 2004 (Berlín, Německo)

  • Tegzova D, Vencovsky J, Dusek L, Pavelka K. Clinical register of TNF alpha blocking therapy of Czech rheumatological society. Project ATTRA. Results of study: Clinical efficacy and safety. Annals of the Rheumatic Diseases 2004; 63(Suppl. 1): 263.
  • Pavelka K, Vencovsky J, Tegzova D, et al. Radiographic progression in RA patiens treated with infliximab data from the Czech National Registry (ATTRA) Annals of the Rheumatic Diseases 2004; 63(Suppl.1): 263.

Odborné příspěvky na českých konferencích

Jáchymovské revmatologické dny
12.–14. 12. 2007, Jáchymov

  • Forejtová Š. Účinnost a bezpečnost biologické léčby AS – výsledky z Registru ATTRA. 
  • Forejtová Š, Pavelka K, Chroust K. Účinnost a bezpečnost anti-TNF alfa terapie u pacientů s ankylozující spondylitidou v Českém národním registru ATTRA.
  • Gatterová J, Pavelka K, Chroust K. Rentgenová progrese revmatoidní artritidy v projektu ATTRA – Enbrel/Case control.
  • Chroust K. Elektronický registr ATTRA.
  • Pavelka K. Bezpečnost biologické terapie u revmatologických onemocnění – bezpečnostní profil adalimumabu.Pavelka K. Způsob léčby AS ve střední a východní Evropě a kvality života nemocných AS. Výsledky mezinárodní multicentrické studie.
  • Šenolt L. Účinnost anti-TNF alfa léčby na extraskeletární projevy ankylozující spondylitidy.
  • Šenolt L. Noviny v biologické léčbě spondylartritid.

ATTRA abstracts at EULAR congresses

  • 2014 FRI0071    EFFECT OF BIOLOGICAL THERAPY ON FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS ,
    L. Sedová, J. Stolfa, M. Urbanova, M. Uher, K. Hejduk
  • 2014 AB0749    EFFECT OF BIOLOGICAL THERAPY ON FATIGUE ON PATIENTS WITH PSORIATIC ARTHRITIS ,
    J. Stolfa, L. Sedova, K. Hejduk, M. Uher
  • 2014 SAT0366   EFFECT OF FIRST-LINE ANTI-TNF THERAPY ON FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS – RESULTS FROM THE CZECH BIOLOGICS REGISTRY ATTRA ,
    S. Forejtova, K. Jarosova, M. Votavova, M. Uher, K. Hejduk, K. Pavelka
  • 2014 THU0168  MONOTHERAPY WITH BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS-DATA FROM THE CZECH REGISTRY ATTRA ,
    H. Mann, Š. Forejtová, K. Jarošová, L. Šenolt, J. Závada, M. Uher, K. Hejduk, K. Pavelka
  • 2014 FRI0322    POSITIVITY FOR RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE IS ASSOCIATED WITH A BETTER DRUG RETENTION OF ABATACEPT: DATA FROM A PANEUROPEAN ANALYSIS OF RA REGISTRIES ,
    J.E. Gottenberg, D. Neto, J. Gomez-Reino, F. Iannone, E. Lie, H. Canhão, K. Pavelka, C. Turesson, M. Hetland, X. Mariette, A. Finckh
  • 2014 FRI0543    PREGNANCY OUTCOME IN ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS TREATED WITH BIOLOGIC AGENTS ,
    K. Jarosova, K. Hejduk, M. Uher, J. Vencovsky

Abstracts from ACR Congresses

  • ABSTRACT NUMBER: 2555 • 2014 ACR/ARHP Annual Meeting The Effect of Co-Medication with Conventional Synthetic (cs)Dmards on Achieving Low Disease Activity While Persisting on Adalimumab Therapy in Patients with Ankylosing Spondylitis/ Axial Spondylarthritis (AS)– Analysis from the Czech Biologics Registry Attra
    Karel Pavelka, Jakub Zavada, Marketa Fojtikova, Sarka Forejtova and Karel Hejduk
  • ABSTRACT NUMBER: 2371 • 2014 ACR/ARHP Annual Meeting Efficacy of First Line Biological Monotherapy in RA: Data from the Czech Registry Attra
    Herman Mann, Sarka Forejtova, Katerina Jarosova, Ladislav Senolt, Jakub Zavada, Michal Uher, Karel Hejduk and Karel Pavelka